Phio Pharmaceuticals Corp. Files 8-K
Ticker: PHIO · Form: 8-K · Filed: May 7, 2025 · CIK: 1533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing
TL;DR
Phio Pharma (formerly RXi) filed an 8-K on 5/7/25. Nothing major, just corporate housekeeping.
AI Summary
Phio Pharmaceuticals Corp. filed an 8-K on May 7, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing indicates the company was formerly known as RXi Pharmaceuticals Corp. and changed its name on October 19, 2011. The company is incorporated in Delaware and its principal executive offices are located in Marlborough, Massachusetts.
Why It Matters
This 8-K filing provides an update on Phio Pharmaceuticals Corp.'s corporate status and historical information, which is relevant for investors tracking the company's official disclosures.
Risk Assessment
Risk Level: low — The filing is primarily administrative and does not appear to contain significant new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Registrant
- RXi Pharmaceuticals Corp (company) — Former company name
- May 7, 2025 (date) — Date of report
- October 19, 2011 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- Marlborough, Massachusetts (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Phio Pharmaceuticals Corp.?
The primary purpose of this 8-K filing is to report "Other Events" and "Financial Statements and Exhibits" as of May 7, 2025.
When did Phio Pharmaceuticals Corp. change its name?
Phio Pharmaceuticals Corp. changed its name from RXi Pharmaceuticals Corp. on October 19, 2011.
Where are Phio Pharmaceuticals Corp.'s principal executive offices located?
Phio Pharmaceuticals Corp.'s principal executive offices are located at 11 Apex Drive, Suite 300A, PMB 2006, Marlborough, Massachusetts 01752.
What is the state of incorporation for Phio Pharmaceuticals Corp.?
Phio Pharmaceuticals Corp. is incorporated in Delaware.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is May 7, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Phio Pharmaceuticals Corp. (PHIO).